(1)
Costanzo, A.; Russo, F.; Galluzzo, M.; Stingeni, L.; Scuderi, R.; Zichichi, L.; Papini, M.; Di Costanzo, L.; Conti, A.; Burlando, M. Secukinumab Exhibits Sustained and Stable Response in Patients With Moderate-to-Severe Psoriasis: Results from the SUPREME Study. Acta Derm Venereol 2021, 101, adv00576.